Underrepresentation of female subjects in BE study to register Generic [Regulatives / Guidelines]

posted by Ohlbe – France, 2020-03-11 15:07 (929 d 08:33 ago) – Posting: # 21251
Views: 4,098

Dear SKM,

» We have done a pilot study with 12 subjects (8 male and 4 female) and the results didn't meet the bioequivalence criteria.

So what ? It is a pilot. Was it powered to demonstrate BE ?

» However, when we exclude the female data it marginally meets the bioequivalency criteria of 80%-125%.

Did you pre-plan this male-only analysis in your protocol or statistical analysis plan ?

» Can we conduct the pivotal study only in Males?

Where do you intend to submit your data ? USA: the FDA wants males and females. Europe: EMA accepts studies in males only, but "we fear that we may fail if we include females" will not be an acceptable rationale.

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
22,390 posts in 4,685 threads, 1,594 registered users;
online 11 (0 registered, 11 guests [including 6 identified bots]).
Forum time: Tuesday 00:41 CEST (Europe/Vienna)

Statistics. A sort of elementary form of mathematics which consists of
adding things together and occasionally squaring them.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5